학술논문
Omniflow® II biosynthetic graft offers acceptable early and mid-term outcomes in redo surgery in patients with critical limb-threatening ischemia with no available autologous vein material
Document Type
Article
Author
Source
In: International Angiology . (International Angiology, April 2024, 43(2):255-261)
Subject
Language
English
ISSN
18271839
03929590
03929590